Items where the Publication is Journal of thrombosis and haemostasis

Number of items: 17.
B
  • Assessing the contribution of fibrinogen in predicting risk of death in men with peripheral arterial disease. (2008) Bartlett, JW; De Stavola, BL; Meade, TW
    • D
  • Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I). (2007) De Stavola, BL; Meade, TW
  • Long-term effects of hemostatic variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study (NPHS-I). (2007) de Stavola, BL; Meade, TW
    • G
  • Economic burden and cost determinants of deep vein thrombosis during 2 years following diagnosis: a prospective evaluation. (2011) Guanella, R; Ducruet, T; Johri, M; Miron, M-J; Roussin, A; Desmarais, S; Joyal, F; Kassis, J; Solymoss, S; Ginsberg, JS; Lamping, DL; Shrier, I; Kahn, SR
    • H
  • Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery Doppler screening at 23 weeks. (2009) Hunt, BJ; Missfelder-Lobos, H; Parra-Cordero, M; Fletcher, O; Parmar, K; Lefkou, E; Lees, CC
    • J
  • Prospective study of circulating soluble CD40 ligand concentrations and the incidence of cardiovascular disease in a nested prospective case-control study of older men and women. (2011) Jefferis, BJ; Whincup, PH; Welsh, P; Wannamethee, SG; Rumley, A; Lawlor, DA; Ebrahim, S; Lowe, GDO
    • K
  • The influence of venous thromboembolism on quality of life and severity of chronic venous disease. (2004) Kahn, SR; M'Lan, CE; Lamping, DL; Kurz, X; Bérard, A; Abenhaim, L; Veines Study Group
  • Determinants of health-related quality of life during the 2 years following deep vein thrombosis. (2008) Kahn, SR; Shbaklo, H; Lamping, DL; Holcroft, CA; Shrier, I; Miron, MJ; Roussin, A; Desmarais, S; Joyal, F; Kassis, J; Solymoss, S; Desjardins, L; Johri, M; Ginsberg, JS
    • L
  • Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacement. (2013) Lalmohamed, A; Vestergaard, P; Jansen, PAF; Grove, EL; de Boer, A; Leufkens, HGM; van Staa, TP; de Vries, F
    • M
  • Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: yes. (2005) Meade, TW
  • The Northwick Park Heart Studies: contrasts between the two factor VII assays used. (2012) Meade, TW; Stirling, Y
  • Predicting the outcomes of using longer-acting prophylactic factor VIII to treat people with severe hemophilia A: a hypothetical decision analysis. (2016) Miners, AH; Krishnan, S; Pasi, KJ
    • O
  • Validation of viscoelastic coagulation tests during cardiopulmonary bypass. (2015) Ortmann, E; Rubino, A; Altemimi, B; Collier, T; Besser, MW; Klein, AA
    • R
  • Tranexamic acid in trauma: how should we use it? (2015) Roberts, I
  • Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial. (2006) Rudnicka, AR; Mt-Isa, S; Meade, TW
    • T
  • The Northwick Park Heart Study: evidence from the laboratory. (2014) Ten Cate, H; Meade, T
    • V
  • The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation. (2013) Van Den Ham, HA; Klungel, OH; Leufkens, HGM; Van Staa, TP